Putative kallikrein substrates and their (patho)biological functions

References

Andrade, D., Assis, D.M., Santos, J.A., Alves, F.M., Hirata, I.Y., Araujo, M.S., Blaber, S.I., Blaber, M., Juliano, M.A., and Juliano, L. (2011). Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates. Biochimie 93, 1701–1709.10.1016/j.biochi.2011.05.037Search in Google Scholar PubMed

Attwood, B.K., Bourgognon, J.M., Patel, S., Mucha, M., Schiavon, E., Skrzypiec, A.E., Young, K.W., Shiosaka, S., Korostynski, M., Piechota, M., et al. (2011). Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 473, 372–375.10.1038/nature09938Search in Google Scholar PubMed PubMed Central

Beaufort, N., Debela, M., Creutzburg, S., Kellermann, J., Bode, W., Schmitt, M., Pidard, D., and Magdolen, V. (2006). Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR). Biol. Chem. 387, 217–222.10.1515/BC.2006.029Search in Google Scholar PubMed

Bernett, M.J., Blaber, S.I., Scarisbrick, I.A., Dhanarajan, P., Thompson, S.M., and Blaber, M. (2002). Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562–24570.10.1074/jbc.M202392200Search in Google Scholar PubMed

Bhoola, K.D., Misso, N.L., Naran, A., and Thompson, P.J. (2007). Current status of tissue kallikrein inhibitors: importance in cancer. Curr. Opin. Investig. Drugs 8, 462–468.Search in Google Scholar

Blaber, S.I., Ciric, B., Christophi, G.P., Bernett, M.J., Blaber, M., Rodriguez, M., and Scarisbrick, I.A. (2004). Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J. 18, 920–922.10.1096/fj.03-1212fjeSearch in Google Scholar PubMed

Borgono, C.A., and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876–890.10.1038/nrc1474Search in Google Scholar PubMed

Borgono, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2, 257–280.10.1158/1541-7786.257.2.5Search in Google Scholar

Borgono, C.A., Gavigan, J.A., Alves, J., Bowles, B., Harris, J.L., Sotiropoulou, G., and Diamandis, E.P. (2007a). Defining the extended substrate specificity of kallikrein 1-related peptidases. Biol. Chem. 388, 1215–1225.10.1515/BC.2007.124Search in Google Scholar PubMed

Borgono, C.A., Michael, I.P., Komatsu, N., Jayakumar, A., Kapadia, R., Clayman, G.L., Sotiropoulou, G., and Diamandis, E.P. (2007b). A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J. Biol. Chem. 282, 3640–3652.10.1074/jbc.M607567200Search in Google Scholar PubMed

Borgono, C.A., Michael, I.P., Shaw, J.L., Luo, L.Y., Ghosh, M.C., Soosaipillai, A., Grass, L., Katsaros, D., and Diamandis, E.P. (2007c). Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. J. Biol. Chem. 282, 2405–2422.10.1074/jbc.M608348200Search in Google Scholar PubMed

Bourgeois, L., Brillard-Bourdet, M., Deperthes, D., Juliano, M.A., Juliano, L., Tremblay, R.R., Dube, J.Y., and Gauthier, F. (1997). Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2. J. Biol. Chem. 272, 29590–29595.10.1074/jbc.272.47.29590Search in Google Scholar

Brattsand, M. and Egelrud, T. (1999). Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274, 30033–30040.10.1074/jbc.274.42.30033Search in Google Scholar

Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y., and Egelrud, T. (2005). A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124, 198–203.10.1111/j.0022-202X.2004.23547.xSearch in Google Scholar

Bredemeyer, A.J., Lewis, R.M., Malone, J.P., Davis, A.E., Gross, J., Townsend, R.R., and Ley, T.J. (2004). A proteomic approach for the discovery of protease substrates. Proc. Natl. Acad. Sci. USA 101, 11785–11790.10.1073/pnas.0402353101Search in Google Scholar

Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., and Hovnanian, A. (2009). Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J. Exp. Med. 206, 1135–1147.10.1084/jem.20082242Search in Google Scholar

Butler, G.S., Dean, R.A., Smith, D., and Overall, C.M. (2009). Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates. Methods Mol. Biol. 528, 159–176.10.1007/978-1-60327-310-7_12Search in Google Scholar

Caliendo, G., Santagada, V., Perissutti, E., Severino, B., Fiorino, F., Frecentese, F., and Juliano, L. (2012). Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development. J. Med. Chem. 55, 6669–6686.10.1021/jm300407tSearch in Google Scholar

Carvalho, A.L., Sanz, L., Barettino, D., Romero, A., Calvete, J.J., and Romao, M.J. (2002). Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA. J. Mol. Biol. 322, 325–337.10.1016/S0022-2836(02)00705-2Search in Google Scholar

Caubet, C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T., Simon, M., and Serre, G. (2004). Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122, 1235–1244.10.1111/j.0022-202X.2004.22512.xSearch in Google Scholar PubMed

Chao, J., Bledsoe, G., Yin, H., and Chao, L. (2006). The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biol. Chem. 387, 665–675.10.1515/BC.2006.085Search in Google Scholar PubMed

Clements, J. (2013). KLK4 is a key regulator of the tumour microenvironment in prostate cancer. 5th International Symposium on Kallikreins and Kallikrein-Related Peptides, 28 September – 1 October 2013, Toronto, Canada.Search in Google Scholar

Cloutier, S.M., Chagas, J.R., Mach, J.P., Gygi, C.M., Leisinger, H.J., and Deperthes, D. (2002). Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. Eur. J. Biochem 269, 2747–2754.10.1046/j.1432-1033.2002.02960.xSearch in Google Scholar

Coombs, G.S., Bergstrom, R.C., Pellequer, J.L., Baker, S.I., Navre, M., Smith, M.M., Tainer, J.A., Madison, E.L., and Corey, D.R. (1998). Substrate specificity of prostate-specific antigen (PSA). Chem. Biol. 5, 475–488.10.1016/S1074-5521(98)90004-7Search in Google Scholar

de Veer, S.J., Swedberg, J.E., Parker, E.A., and Harris, J.M. (2012). Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14. Biol. Chem. 393, 331–341.10.1515/bc-2011-250Search in Google Scholar

Debela, M., Magdolen, V., Grimminger, V., Sommerhoff, C., Messerschmidt, A., Huber, R., Friedrich, R., Bode, W., and Goettig, P. (2006a). Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J. Mol. Biol. 362, 1094–1107.10.1016/j.jmb.2006.08.003Search in Google Scholar

Debela, M., Magdolen, V., Schechter, N., Valachova, M., Lottspeich, F., Craik, C.S., Choe, Y., Bode, W., and Goettig, P. (2006b). Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J. Biol. Chem. 281, 25678–25688.10.1074/jbc.M602372200Search in Google Scholar

Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N.M., and Bode, W. (2007a). Structural basis of the zinc inhibition of human tissue kallikrein 5. J. Mol. Biol. 373, 1017–1031.10.1016/j.jmb.2007.08.042Search in Google Scholar

Debela, M., Hess, P., Magdolen, V., Schechter, N.M., Steiner, T., Huber, R., Bode, W., and Goettig, P. (2007b). Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7. Proc. Natl. Acad. Sci. USA 104, 16086–16091.10.1073/pnas.0707811104Search in Google Scholar

Deperthes, D., Frenette, G., Brillard-Bourdet, M., Bourgeois, L., Gauthier, F., Tremblay, R.R., and Dube, J.Y. (1996). Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J. Androl. 17, 659–665.Search in Google Scholar

Deperthes, D., Marceau, F., Frenette, G., Lazure, C., Tremblay, R.R., and Dube, J.Y. (1997). Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none. Biochim. Biophys. Acta 1343, 102–106.10.1016/S0167-4838(97)00135-0Search in Google Scholar

Descargues, P., Deraison, C., Prost, C., Fraitag, S., Mazereeuw-Hautier, J., D’Alessio, M., Ishida-Yamamoto, A., Bodemer, C., Zambruno, G., and Hovnanian, A. (2006). Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. J. Invest. Dermatol. 126, 1622–1632.10.1038/sj.jid.5700284Search in Google Scholar PubMed

Dix, M.M., Simon, G.M., Wang, C., Okerberg, E., Patricelli, M.P., and Cravatt, B.F. (2012). Functional interplay between caspase cleavage and phosphorylation sculpts the apoptotic proteome. Cell 150, 426–440.10.1016/j.cell.2012.05.040Search in Google Scholar PubMed PubMed Central

Eissa, A., Amodeo, V., Smith, C.R., and Diamandis, E.P. (2011). Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. J. Biol. Chem. 286, 687–706.10.1074/jbc.M110.125310Search in Google Scholar

Emami, N., Deperthes, D., Malm, J., and Diamandis, E.P. (2008). Major role of human KLK14 in seminal clot liquefaction. J. Biol. Chem. 283, 19561–19569.10.1074/jbc.M801194200Search in Google Scholar

Felber, L.M., Borgono, C.A., Cloutier, S.M., Kundig, C., Kishi, T., Ribeiro Chagas, J., Jichlinski, P., Gygi, C.M., Leisinger, H.J., Diamandis, E.P., et al. (2005). Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Biol. Chem. 386, 291–298.10.1515/BC.2005.035Search in Google Scholar

Fortugno, P., Bresciani, A., Paolini, C., Pazzagli, C., El Hachem, M., D’Alessio, M., and Zambruno, G. (2011). Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis. J. Invest. Dermatol. 131, 2223–2232.10.1038/jid.2011.174Search in Google Scholar

Ghosh, M.C., Grass, L., Soosaipillai, A., Sotiropoulou, G., and Diamandis, E.P. (2004). Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25, 193–199.10.1159/000081102Search in Google Scholar

Goettig, P., Magdolen, V., and Brandstetter, H. (2010). Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs). Biochimie 92, 1546–1567.10.1016/j.biochi.2010.06.022Search in Google Scholar

Guillon-Munos, A., Oikonomopoulou, K., Michel, N., Smith, C.R., Petit-Courty, A., Canepa, S., Reverdiau, P., Heuze-Vourc’h, N., Diamandis, E.P., and Courty, Y. (2011). Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors. J. Biol. Chem. 286, 25505–25518.10.1074/jbc.M110.213231Search in Google Scholar

Hachem, J.P., Wagberg, F., Schmuth, M., Crumrine, D., Lissens, W., Jayakumar, A., Houben, E., Mauro, T.M., Leonardsson, G., Brattsand, M., et al. (2006). Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J. Invest. Dermatol. 126, 1609–1621.10.1038/sj.jid.5700288Search in Google Scholar

Hansson, L., Stromqvist, M., Backman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. (1994). Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269, 19420–19426.10.1016/S0021-9258(17)32185-3Search in Google Scholar

Hansson, L., Backman, A., Ny, A., Edlund, M., Ekholm, E., Ekstrand Hammarstrom, B., Tornell, J., Wallbrandt, P., Wennbo, H., and Egelrud, T. (2002). Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J. Invest. Dermatol. 118, 444–449.10.1046/j.0022-202x.2001.01684.xSearch in Google Scholar PubMed

He, X.P., Shiosaka, S., and Yoshida, S. (2001). Expression of neuropsin in oligodendrocytes after injury to the CNS. Neurosci. Res. 39, 455–462.10.1016/S0168-0102(01)00200-0Search in Google Scholar

Hollenberg, M.D., Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Ramachandran, R., and Diamandis, E.P. (2008). Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol. Chem. 389, 643–651.10.1515/BC.2008.077Search in Google Scholar PubMed

Johnson, S.K., Ramani, V.C., Hennings, L., and Haun, R.S. (2007). Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109, 1811–1820.10.1002/cncr.22606Search in Google Scholar PubMed

Kapadia, C., Ghosh, M.C., Grass, L., and Diamandis, E.P. (2004). Human kallikrein 13 involvement in extracellular matrix degradation. Biochem. Biophys. Res. Commun. 323, 1084–1090.10.1016/j.bbrc.2004.08.206Search in Google Scholar PubMed

Kasza, A. (2013). IL-1 and EGF regulate expression of genes important in inflammation and cancer. Cytokine 62, 22–33.10.1016/j.cyto.2013.02.007Search in Google Scholar PubMed

Katz, B.A., Liu, B., Barnes, M., and Springman, E.B. (1998). Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution. Protein Sci. 7, 875–885.10.1002/pro.5560070405Search in Google Scholar PubMed PubMed Central

Killian, C.S., Corral, D.A., Kawinski, E., and Constantine, R.I. (1993). Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors. Biochem. Biophys. Res. Commun. 192, 940–947.10.1006/bbrc.1993.1506Search in Google Scholar PubMed

Kleifeld, O., Doucet, A., auf dem Keller, U., Prudova, A., Schilling, O., Kainthan, R.K., Starr, A.E., Foster, L.J., Kizhakkedathu, J.N., and Overall, C.M. (2010). Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat. Biotechnol. 28, 281–288.10.1038/nbt.1611Search in Google Scholar PubMed

Klucky, B., Mueller, R., Vogt, I., Teurich, S., Hartenstein, B., Breuhahn, K., Flechtenmacher, C., Angel, P., and Hess, J. (2007). Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 67, 8198–8206.10.1158/0008-5472.CAN-07-0607Search in Google Scholar PubMed

Krenzer, S., Peterziel, H., Mauch, C., Blaber, S.I., Blaber, M., Angel, P., and Hess, J. (2011). Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment. J. Invest. Dermatol. 131, 2281–2288.10.1038/jid.2011.190Search in Google Scholar PubMed PubMed Central

Li, H.X., Hwang, B.Y., Laxmikanthan, G., Blaber, S.I., Blaber, M., Golubkov, P.A., Ren, P., Iverson, B.L., and Georgiou, G. (2008). Substrate specificity of human kallikreins 1 and 6 determined by phage display. Protein Sci. 17, 664–672.10.1110/ps.073333208Search in Google Scholar

Lilja, H., Oldbring, J., Rannevik, G., and Laurell, C.B. (1987). Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J. Clin. Invest. 80, 281–285.10.1172/JCI113070Search in Google Scholar

Lima, A.R., Alves, F.M., Angelo, P.F., Andrade, D., Blaber, S.I., Blaber, M., Juliano, L., and Juliano, M.A. (2008). S(1)’ and S(2)’ subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen. Biol. Chem. 389, 1487–1494.10.1515/BC.2008.166Search in Google Scholar

Lovgren, J., Airas, K., and Lilja, H. (1999). Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors. Eur. J. Biochem. 262, 781–789.10.1046/j.1432-1327.1999.00433.xSearch in Google Scholar

Magklara, A., Mellati, A.A., Wasney, G.A., Little, S.P., Sotiropoulou, G., Becker, G.W., and Diamandis, E.P. (2003). Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun. 307, 948–955.10.1016/S0006-291X(03)01271-3Search in Google Scholar

Malm, J., Hellman, J., Hogg, P., and Lilja, H. (2000). Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor. Prostate 45, 132–139.10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3Search in Google Scholar

Matsumura, M., Bhatt, A.S., Andress, D., Clegg, N., Takayama, T.K., Craik, C.S., and Nelson, P.S. (2005). Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate 62, 1–13.10.1002/pros.20101Search in Google Scholar

Michael, I.P., Sotiropoulou, G., Pampalakis, G., Magklara, A., Ghosh, M., Wasney, G., and Diamandis, E.P. (2005). Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J Biol. Chem. 280, 14628–14635.10.1074/jbc.M408132200Search in Google Scholar

Michael, I.P., Pampalakis, G., Mikolajczyk, S.D., Malm, J., Sotiropoulou, G., and Diamandis, E.P. (2006). Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. J. Biol. Chem. 281, 12743–12750.10.1074/jbc.M600326200Search in Google Scholar

Mitsui, S., Okui, A., Uemura, H., Mizuno, T., Yamada, T., Yamamura, Y., and Yamaguchi, N. (2002). Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer’s disease. Ann. NY Acad. Sci. 977, 216–223.10.1111/j.1749-6632.2002.tb04818.xSearch in Google Scholar

Mize, G.J., Wang, W., and Takayama, T.K. (2008). Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2. Mol. Cancer Res. 6, 1043–1051.10.1158/1541-7786.MCR-08-0096Search in Google Scholar PubMed

Niessen, S., Hoover, H., and Gale, A.J. (2011). Proteomic analysis of the coagulation reaction in plasma and whole blood using PROTOMAP. Proteomics 11, 2377–2388.10.1002/pmic.201000674Search in Google Scholar PubMed

Noorbakhsh, F., Tsutsui, S., Vergnolle, N., Boven, L.A., Shariat, N., Vodjgani, M., Warren, K.G., Andrade-Gordon, P., Hollenberg, M.D., and Power, C. (2006). Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203, 425–435.10.1084/jem.20052148Search in Google Scholar PubMed PubMed Central

Nylander-Lundqvist, E. and Egelrud, T. (1997). Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm. Venereol. 77, 203–206.Search in Google Scholar

Obiezu, C.V., Michael, I.P., Levesque, M.A., and Diamandis, E.P. (2006). Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins. Biol. Chem. 387, 749–759.10.1515/BC.2006.094Search in Google Scholar PubMed

Ogawa, K., Yamada, T., Tsujioka, Y., Taguchi, J., Takahashi, M., Tsuboi, Y., Fujino, Y., Nakajima, M., Yamamoto, T., Akatsu, H., et al. (2000). Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer’s disease and Parkinson’s disease. Psychiatry Clin. Neurosci. 54, 419–426.10.1046/j.1440-1819.2000.00731.xSearch in Google Scholar PubMed

Ohler, A., Debela, M., Wagner, S., Magdolen, V., and Becker-Pauly, C. (2010). Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol. Chem. 391, 455–460.10.1515/bc.2010.023Search in Google Scholar PubMed

Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G.S., Bunnett, N.W., et al. (2006). Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 281, 32095–32112.10.1074/jbc.M513138200Search in Google Scholar PubMed

Oikonomopoulou, K., Diamandis, E.P., and Hollenberg, M.D. (2010). Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier. Biol. Chem. 391, 299–310.10.1515/bc.2010.038Search in Google Scholar

Oikonomopoulou, K., DeAngelis, R.A., Chen, H., Diamandis, E.P., Hollenberg, M.D., Ricklin, D., and Lambris, J.D. (2013). Induction of complement C3a receptor responses by kallikrein-related peptidase 14. J. Immunol. 191, 3858–3866.10.4049/jimmunol.1202999Search in Google Scholar PubMed PubMed Central

Ramachandran, R., Noorbakhsh, F., Defea, K., and Hollenberg, M.D. (2013). Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat. Rev. Drug Discov. 11, 69–86.10.1038/nrd3615Search in Google Scholar PubMed

Ramani, V.C. and Haun, R.S. (2008). The extracellular matrix protein fibronectin is a substrate for kallikrein 7. Biochem. Biophys. Res. Commun. 369, 1169–1173.10.1016/j.bbrc.2008.03.021Search in Google Scholar PubMed

Ramani, V.C., Kaushal, G.P., and Haun, R.S. (2011). Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains. Biochim. Biophys. Acta 1813, 1525–1531.10.1016/j.bbamcr.2011.05.007Search in Google Scholar PubMed PubMed Central

Rehault, S., Monget, P., Mazerbourg, S., Tremblay, R., Gutman, N., Gauthier, F., and Moreau, T. (2001). Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. Eur. J. Biochem. 268, 2960–2968.10.1046/j.1432-1327.2001.02185.xSearch in Google Scholar PubMed

Robert, M. and Gagnon, C. (1996). Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin. Biol. Reprod. 55, 813–821.10.1095/biolreprod55.4.813Search in Google Scholar PubMed

Sakabe, J., Yamamoto, M., Hirakawa, S., Motoyama, A., Ohta, I., Tatsuno, K., Ito, T., Kabashima, K., Hibino, T., and Tokura, Y. (2013). Kallikrein-related peptidase 5 functions in proteolytic processing of profilaggrin in cultured human keratinocytes. J. Biol. Chem. 288, 17179–17189.10.1074/jbc.M113.476820Search in Google Scholar PubMed PubMed Central

Scarisbrick, I.A., Towner, M.D., and Isackson, P.J. (1997). Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury. J. Neurosci. 17, 8156–8168.10.1523/JNEUROSCI.17-21-08156.1997Search in Google Scholar

Scarisbrick, I.A., Sabharwal, P., Cruz, H., Larsen, N., Vandell, A.G., Blaber, S.I., Ameenuddin, S., Papke, L.M., Fehlings, M.G., Reeves, R.K., et al. (2006). Dynamic role of kallikrein 6 in traumatic spinal cord injury. Eur. J. Neurosci. 24, 1457–1469.10.1111/j.1460-9568.2006.05021.xSearch in Google Scholar PubMed

Schilling, O. and Overall, C.M. (2007). Proteomic discovery of protease substrates. Curr. Opin. Chem. Biol. 11, 36–45.10.1016/j.cbpa.2006.11.037Search in Google Scholar PubMed

Schilling, O. and Overall, C.M. (2008). Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat. Biotechnol. 26, 685–694.10.1038/nbt1408Search in Google Scholar PubMed

Shahinian, H., Loessner, D., Biniossek, M.L., Kizhakkedathu, J.N., Clements, J.A., Magdolen, V., and Schilling, O. (2013). Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFbeta-1 signaling in ovarian cancer cells. Mol. Oncol. 8, 68–82.10.1016/j.molonc.2013.09.003Search in Google Scholar PubMed PubMed Central

Sharma, N., Oikonomopoulou, K., Ito, K., Renaux, B., Diamandis, E.P., Hollenberg, M.D., and Rancourt, D.E. (2008). Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display. Biol. Chem. 389, 1097–1105.10.1515/BC.2008.118Search in Google Scholar PubMed

Shaw, J.L. and Diamandis, E.P. (2008). A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology. Biol. Chem. 389, 681–688.10.1515/BC.2008.069Search in Google Scholar PubMed

Shen, C., Yu, Y., Li, H., Yan, G., Liu, M., Shen, H., and Yang, P. (2012). Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN2 centered network. Proteomics 12, 1917–1927.10.1002/pmic.201200027Search in Google Scholar PubMed

Sher, Y.P., Chou, C.C., Chou, R.H., Wu, H.M., Wayne Chang, W.S., Chen, C.H., Yang, P.C., Wu, C.W., Yu, C.L., and Peck, K. (2006). Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res. 66, 11763–11770.10.1158/0008-5472.CAN-06-3165Search in Google Scholar PubMed

Simmer, J.P., Hu, Y., Lertlam, R., Yamakoshi, Y., and Hu, J.C. (2009). Hypomaturation enamel defects in Klk4 knockout/LacZ knockin mice. J. Biol. Chem. 284, 19110–19121.10.1074/jbc.M109.013623Search in Google Scholar PubMed PubMed Central

Smith, H.W. and Marshall, C.J. (2010). Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell Biol 11, 23–36.10.1038/nrm2821Search in Google Scholar PubMed

Sotiropoulou, G., Rogakos, V., Tsetsenis, T., Pampalakis, G., Zafiropoulos, N., Simillides, G., Yiotakis, A., and Diamandis, E.P. (2003). Emerging interest in the kallikrein gene family for understanding and diagnosing cancer. Oncol. Res. 13, 381–391.10.3727/096504003108748393Search in Google Scholar PubMed

Spencer, B., Michael, S., Shen, J., Kosberg, K., Rockenstein, E., Patrick, C., Adame, A., and Masliah, E. (2013). Lentivirus mediated delivery of neurosin promotes clearance of wild-type alpha-synuclein and reduces the pathology in an alpha-synuclein model of LBD. Mol. Ther. 21, 31–41.10.1038/mt.2012.66Search in Google Scholar PubMed PubMed Central

Staes, A., Impens, F., Van Damme, P., Ruttens, B., Goethals, M., Demol, H., Timmerman, E., Vandekerckhove, J., and Gevaert, K. (2011). Selecting protein N-terminal peptides by combined fractional diagonal chromatography. Nat. Protoc. 6, 1130–1141.10.1038/nprot.2011.355Search in Google Scholar PubMed

Stefansson, K., Brattsand, M., Roosterman, D., Kempkes, C., Bocheva, G., Steinhoff, M., and Egelrud, T. (2008). Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J. Invest. Dermatol. 128, 18–25.10.1038/sj.jid.5700965Search in Google Scholar PubMed

Sueiras-Diaz, J., Jones, D.M., Ashworth, D., Horton, J., Evans, D.M., and Szelke, M. (1994). Cleavage of human kininogen fragments at Met-Lys by human tissue kallikrein. Braz. J. Med. Biol. Res. 27, 1935–1942.Search in Google Scholar

Takayama, T.K., McMullen, B.A., Nelson, P.S., Matsumura, M., and Fujikawa, K. (2001). Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Biochemistry 40, 15341–15348.10.1021/bi015775eSearch in Google Scholar PubMed

Veveris-Lowe, T.L., Kruger, S.J., Walsh, T., Gardiner, R.A., and Clements, J.A. (2007). Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches. Semin. Thromb. Hemost. 33, 87–99.10.1055/s-2006-958467Search in Google Scholar PubMed

Webber, M.M., Waghray, A., and Bello, D. (1995). Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin. Cancer Res. 1, 1089–1094.Search in Google Scholar

Yamakoshi, Y., Hu, J.C., Fukae, M., Yamakoshi, F., and Simmer, J.P. (2006). How do enamelysin and kallikrein 4 process the 32-kDa enamelin? Eur. J. Oral Sci. 114 Suppl 1, 45–51; discussion 93–45, 379–380.Search in Google Scholar

Yamakoshi, Y., Simmer, J.P., Bartlett, J.D., Karakida, T., and Oida, S. (2013). MMP20 and KLK4 activation and inactivation interactions in vitro. Arch. Oral Biol. 58, 1569–1577.10.1016/j.archoralbio.2013.08.005Search in Google Scholar PubMed PubMed Central

Yamamoto, M., Miyai, M., Matsumoto, Y., Tsuboi, R., and Hibino, T. (2012). Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form. J. Biol. Chem. 287, 32825–32834.10.1074/jbc.M112.357467Search in Google Scholar PubMed PubMed Central

Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R.A., Schechter, N.M., Bonnart, C., Descargues, P., Hovnanian, A., and Gallo, R.L. (2006). Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068–2080.10.1096/fj.06-6075comSearch in Google Scholar PubMed

Yoi, O.O., Seldin, D.C., Spragg, J., Pinkus, G.S., and Austen, K.F. (1979). Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase. Proc. Natl. Acad. Sci. USA 76, 3612–3616.10.1073/pnas.76.8.3612Search in Google Scholar PubMed PubMed Central

Yoshida, S. (2010). Klk8, a multifunctional protease in the brain and skin: analysis of knockout mice. Biol. Chem. 391, 375–380.10.1515/bc.2010.034Search in Google Scholar PubMed

Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184–204.Search in Google Scholar